TAMPA, Fla. & KIRYAT ONO, Israel--(BUSINESS WIRE)--UTEK Corporation (AMEX & LSE-AIM: UTK) a specialty finance company focused on technology transfer, and GammaCan International, Inc (OTC BB: GCAN), a developer of immunotherapies for the treatment of melanoma, cancers and other diseases, are pleased to announce that they have signed a strategic alliance agreement.
